Edition:
United States

Profile: Pfizer Inc (PFE)

PFE on New York Consolidated

36.20USD
17 Oct 2017
Change (% chg)

$0.22 (+0.61%)
Prev Close
$35.98
Open
$35.93
Day's High
$36.33
Day's Low
$35.75
Volume
14,019,661
Avg. Vol
17,421,057
52-wk High
$36.60
52-wk Low
$29.83

Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development and manufacture of healthcare products. Its global portfolio includes medicines and vaccines, as well as consumer healthcare products. The Company manages its commercial operations through two business segments: Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). IH focuses on developing and commercializing medicines and vaccines, as well as products for consumer healthcare. IH therapeutic areas include internal medicine, vaccines, oncology, inflammation and immunology, rare diseases and consumer healthcare. EH includes legacy brands, branded generics, generic sterile injectable products, biosimilars and infusion systems. EH also includes a research and development (R&D) organization, as well as its contract manufacturing business. Its brands include Prevnar 13, Xeljanz, Eliquis, Lipitor, Celebrex, Pristiq and Viagra.

Company Address

Pfizer Inc

235 E 42ND ST
NEW YORK   NY   10017-5703
P: +1212.5732323
F: +1302.6555049

Company Web Links